Ultra Violette Withdraws Sunscreen Following Concerns Over SPF Accuracy

DOWNLOAD IPFS

Australian skincare company Ultra Violette has pulled its Lean Screen SPF 50+ Mattifying Zinc Sunscreen from shelves after independent testing raised concerns about the product’s effectiveness. Multiple tests showed a significant variation in sun protection factor (SPF) readings, with some results as low as SPF 4, well below the advertised SPF 50+. The recall underscores the importance of rigorous testing in the sunscreen industry and highlights potential risks to consumers relying on labeled SPF claims.

Earlier in 2025, consumer advocacy group Choice tested 20 popular sunscreens and found that 16 failed to meet their labeled SPF levels. Lean Screen performed the worst in these tests, producing a reading as low as SPF 4. Ultra Violette defended the product by citing overseas laboratory results indicating SPF levels above 60. However, an ABC investigation questioned the reliability of these tests, particularly those conducted by Princeton Consumer Research, a lab widely used by sunscreen manufacturers for SPF certification. These discrepancies prompted increased scrutiny of the product’s safety and performance.

In response, Ultra Violette commissioned additional independent tests from multiple laboratories. The results revealed significant variability, confirming concerns about consistency and effectiveness. The company acknowledged the issue, stating that the performance of Lean Screen “was not good enough” and did not meet consumer expectations. Ultra Violette emphasized that the problem was specific to Lean Screen and did not affect its other sunscreen products.

Ultra Violette has committed to transparency and consumer safety, apologizing to its customers and outlining steps to correct the issue. The company plans to work closely with regulatory authorities to ensure all products meet strict quality and safety standards moving forward. This includes reviewing manufacturing processes, testing protocols, and third-party certification methods to restore consumer confidence in its brand.

The withdrawal of Lean Screen highlights broader challenges in the skincare and sunscreen industry, where discrepancies between labeled SPF and actual performance can pose serious risks to consumers. Experts note that SPF is a critical factor in preventing skin damage, including sunburn and long-term risks such as skin cancer. Products that fail to deliver their advertised protection may leave users exposed to harmful ultraviolet radiation, particularly during extended outdoor activities.

Industry analysts suggest that the Ultra Violette case could prompt more rigorous regulatory oversight of sunscreen products in Australia. Consistent, reliable testing and independent verification are essential to ensuring that consumers receive the level of protection advertised on packaging. Manufacturers are increasingly expected to provide evidence of consistent SPF performance through repeated trials and accredited laboratory certification.

Consumers are advised to exercise caution when selecting sunscreen products and to consult reliable sources for guidance on SPF effectiveness. Dermatologists recommend using broad-spectrum sunscreen, applying it correctly, and reapplying regularly, regardless of the SPF rating on the label. Ultra Violette’s experience serves as a reminder of the importance of vigilance and independent testing in maintaining public trust in sun protection products.

The Lean Screen recall reflects Ultra Violette’s proactive approach to addressing performance concerns and demonstrates the company’s willingness to prioritize consumer safety. As the brand works to restore confidence in its product line, the incident reinforces the broader responsibility of skincare companies to ensure accurate SPF labeling and reliable sun protection for all users.